Inventor · disambiguated record
Yasushi Hattori
Also filed as: HATTORI YASUSHI
23 granted patents·7 pending applications·95 citations·filing 2013–2025
95Inventor score
Files withTAKEDA PHARMACEUTICALS CO30
Top patents by PatentIndex Score
30 records- 0197US10428023B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Oct 1, 2019·22 cites·1 claims
- 0296US10584097B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Mar 10, 2020·14 cites·1 claims
- 0395US11028048B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Jun 8, 2021·8 cites·9 claims
- 0494US11440883B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Sep 13, 2022·3 cites·1 claims
- 0593US9718814B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Aug 1, 2017·5 cites·2 claims
- 0693US9714241B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Jul 25, 2017·5 cites·2 claims
- 0793US9487511B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Nov 8, 2016·5 cites·2 claims
- 0889US10053456B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2015·Granted Aug 21, 2018·3 cites·7 claims
- 0988US11987586B1Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonistsTAKEDA PHARMACEUTICALS CO·Filed 2023·Granted May 21, 2024·1 cites·16 claims
- 1088US9751885B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2013·Granted Sep 5, 2017·15 cites·10 claims
- 1187US11319286B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted May 3, 2022·4 cites·10 claims
- 1286US10106556B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Oct 23, 2018·8 cites·20 claims
- 1386US2024317733A1Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1486US2024360080A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1584US11655241B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted May 23, 2023·2 cites·15 claims
- 1680US12421188B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 23, 2025·0 cites·19 claims
- 1780US12415782B2Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 16, 2025·0 cites·19 claims
- 1880US12404237B2Method of treating excessive sleepiness and/or cataplexy using n-{2-(([1,1′-biphenyl]-3-yl)methyl)pyrrolidin-3-yl}sulfonamide derivativesTAKEDA PHARMACEUTICALS CO·Filed 2025·Granted Sep 2, 2025·0 cites·19 claims
- 1976US2023063805A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2075US10968213B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Apr 6, 2021·0 cites·1 claims
- 2175US2021276949A1Heterocyclic compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2275US2021179603A1Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2021·Application pending·0 cites
- 2370US10414761B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Sep 17, 2019·0 cites·1 claims
- 2466US9920047B2Cyclopropanamine compound and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2016·Granted Mar 20, 2018·0 cites·1 claims
- 2563US2024309016A1Macrocyclic heterocycle compounds and use thereofTAKEDA PHARMACEUTICALS CO·Filed 2024·Application pending·0 cites
- 2655US2025250230A1Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 2753US12077522B2Heterocyclic compound and application thereofTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 3, 2024·0 cites·11 claims
- 2852US12091410B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Sep 17, 2024·0 cites·13 claims
- 2951US12448377B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Oct 21, 2025·0 cites·16 claims
- 3051US12071434B2Heterocyclic compoundTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Aug 27, 2024·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Yasushi Hattori files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →